Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AKris M. White, Adolfo García‐Sastre, Romel Rosales et al.|Science|2021Cited by 364
Virus-induced senescence is a driver and therapeutic target in COVID-19Soyoung Lee, Clemens A. Schmitt, Emanuel Wyler et al.|Nature|2021Cited by 344
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune seraRaveen Rathnasinghe, Michael Schotsaert, Sonia Jangra et al.|Nature Communications|2022Cited by 41